Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007

Mary Allen Staat1, Marie R Griffin, Stephanie Donauer

  • 1Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, United States. mary.staat@cchmc.org

Vaccine
|September 28, 2011
PubMed

Insights

The influenza vaccine demonstrated 56% effectiveness in preventing medically attended, confirmed influenza in young children aged 6-59 months. Partial vaccination did not show a significant protective effect against influenza illness.

Area of Science:

  • Pediatrics
  • Vaccinology
  • Infectious Diseases

Background:

  • Influenza poses a significant health risk to young children, leading to medical care visits.
  • Estimating influenza vaccine effectiveness (VE) is crucial for public health strategies.
  • Previous studies highlight the importance of vaccination in pediatric populations.

Purpose of the Study:

  • To determine the effectiveness of the influenza vaccine in preventing laboratory-confirmed influenza in children.
  • To assess VE against medical care visits for influenza in children aged 6-59 months.
  • To compare effectiveness between fully and partially vaccinated children.

Main Methods:

  • A matched case-control study was conducted from 2005-2007.
  • Participants included children presenting with acute respiratory illness or fever.
  • Influenza vaccine effectiveness was calculated using confirmed influenza cases and influenza-negative controls.

Main Results:

  • The influenza vaccine showed 56% effectiveness (95% CI: 25%-74%) in fully vaccinated children aged 6-59 months.
  • A statistically significant VE was not observed for partially vaccinated children.
  • The study focused on preventing medically attended, laboratory-confirmed influenza.

Conclusions:

  • Full vaccination against influenza provides significant protection for young children against medically attended illness.
  • Partial influenza vaccination may not offer sufficient protection in this age group.
  • These findings support robust influenza vaccination programs for children.